Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study: The LIPL-PLATELET Study
2017-003483-12Phase 3Completed
- Sponsor
- Verein zur Förderung der Forschung auf dem Gebiet der Arteriosklerose, Thrombose und Gefäßkrankheiten
- Start
- Oct 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of alirocumab, rosuvastatin and atorvastatin in coronary arteriosclerosis (2 arms), sponsored by Verein zur Förderung der Forschung auf dem Gebiet der Arteriosklerose, Thrombose und Gefäßkrankheiten. Started Oct 2017; status: completed.
02
Drugs
alirocumabrosuvastatinatorvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2017-003483-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003483-12.